Decisions about add-on reimbursement for medical devices in France in May 2019

26

Jun 2019

The French National Authority for Health (HAS) released new decisions about add-on and medical aid reimbursement of many medical devices from the meetings of the National Commission for Evaluation of Medical Devices and Health Technologies (CNEDiMTS) in May 2019.

Eleven (11) decisions were released regarding orthopedic devices:

  • VANDA_D, long-lasting series therapeutic shoes for adults (application for registration, approved)
  • VENEZIA_D, long-lasting series therapeutic shoes for adults (application for registration, approved)
  • OCTAVIO_D, long-lasting series therapeutic shoes for adults (application for registration, approved)
  • VELINA_D, long-lasting series therapeutic shoes for adults (application for registration, approved)
  • ORFEO_D, long-lasting series therapeutic shoes for adults (application for registration, approved)
  • VALENTINA_D, long-lasting series therapeutic shoes for adults (application for registration, approved)
  • FIXA DUPLEX (to be cemented), double mobility cup with cemented cup and conventional polyethylene or highly cross-linked polyethylene insert (application for registration, approved)
  • FIXA DUPLEX (without cement), double mobility cup with cemented cup and conventional polyethylene or highly cross-linked polyethylene insert (application for registration, approved)
  • ONIRIS PRO, mandibular advancement orthosis (OAM) (application for registration, approved)
  • ARGUS II, retinal prosthesis system (application for registration, approved)
  • MENISCAL CINCH II, meniscal anchor (application for registration, approved)

 

Two (2) decisions were released for cardiovascular devices:

  • AVANTGARDE CHRONO CARBOSTENT,  coronary endoprosthesis (stent) coated with carbon (product without pharmacological action) (renewal of registration, approved)
  • ELUNIR, coronary endoprosthesis (stent) coated with ridaforolimus (pharmacologically active product) (administrative amendment - changes in the wording, thus packaging and labelling)

Eleven (11) decisions were released for other devices:

  • COLLECTEUR EXPRESS, Drain collecting system for high flow liquid stool (change of indications and renewal of registration, approved)
  • SOLOIST, radiofrequency needle electrodes (application for registration, approved)
  • LEVEEN, radiofrequency needle electrodes (application for registration, approved)
  • INVACARE COLIBRI OUTDOOR 4 WHEELS, modular electric scooter (application for registration, approved)
  • INTERSTIM I, neuromodulator of sacral roots (cancelled)
  • FREESTYLE OPTIUM NEO, apparatus for automated automatic reading of blood glucose and ketones (renewal of registration, approved)
  • DIGISONIC SP ABI, brainstem implant (renewal of registration, approved)
  • Mi1200 SYNCHRONY ABI and Mi1200 SYNCHRONY PIN ABI, brainstem implant (renewal of registration, approved)
  • CATIONORM in multidose vial, emulsion for ophthalmic use (renewal of registration, approved)
  • CATIONORM in single doses, emulsion for ophthalmic use (renewal of registration, approved)
  • DIGI SP - SPK DIGI - DIGISONIC BTE – ZEBRA, sound processor (cancelled)

See the list of decisions in French here.

Subscribe to our newsletter delivered every second week not to miss important reimbursement information.

The latest related news

24

Mar 2022

The HTA body of the Tuscany Regional Healthcare issues two types of documents: HTA forms and motivational forms. With a regional decree 2472 of February 10, 2022, Tuscany Regional Healthcare has published assessments of five medical devices of various therapeutic areas, such as cardiovascular and peripheral vascular areas.

Read more

18

Mar 2022

On February 22, 2022, a repository of innovative acts outside the nomenclature of biology and anatomopathology (RIHN) and a Supplementary list of IVD tests were published. Minor changes were introduced in the 2022 RIHN list.

Read more

14

Mar 2022

In February 2021, the Clinical Coding and Schedule Development (CCSD) working group, which develops and maintains procedural and diagnostics nomenclature for private payers in England, published Bulletins 0182 and 0079 with changes to be implemented no later than April 10, 2022. Three new procedure codes concerned robotic surgery in orthopaedic area, spinal procedures, and ophthalmology, and five new diagnostic codes were introduced.

Read more

11

Mar 2022

On February 07, 2022, the Dental and Pharmaceutical Benefits Agency has announced the withdrawal of the assessments of the PhysioMem PM 100 and CardioMem CM 100 XT and the finalization of the assessments of the Zenicor ECG, Coala Heart Monitor Pro, and KardiaMobile. For the conducted assessments, it was outlined that the portable devices provide more limited information than standard ECG measurements; therefore, it was mainly estimated for atrial fibrillation.

Read more

10

Mar 2022

In February 2022, the Finnish Coordinating Center for Health Technology Assessment announced the release of the seven accomplished rapid hospital assessments performed by the Helsinki, Tampere, and Oulu University Hospital. The accomplished rapid HTAs concern the diagnostic imaging, e-Health, endocrine, endoscopy, men’s health, neuromodulation technology groups.

Read more